NIH-funded research R01 grant

New kidney biomarkers to catch type 1 diabetes kidney disease early

Official title: Novel biomarkers of kidney disease in type 1 diabetes

Funded at University of Pittsburgh at Pittsburgh · NIH-11364285 · Data updated 2026-11-12

This study looks for tiny clues in urine and blood that predict kidney trouble early in people with type 1 diabetes.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startJune 12, 2026
Project endMarch 31, 2030
Funding year2026
Award (this year)$812,862
NIH project number1R01DK143566-01A1
Project IDNIH-11364285 on NIH RePORTER

Who could benefit from this research

Could help

Adults with type 1 diabetes who are at risk for or beginning signs of diabetic kidney disease, including African American individuals.

Less likely to help

Patients without or with very stable kidney function may see little to no direct benefit.

What this research studies

Kidney disease is a major risk for people with type 1 diabetes, and current screens often miss the earliest changes. The researchers will analyze the urinary peptidome and degradome to find new, minimally invasive markers that predict rapid kidney function decline before traditional tests worsen. They will compare urine and plasma samples over time to see which biomarkers best forecast progression toward worse kidney outcomes. This work aims to tailor monitoring and future therapies to prevent dialysis or kidney failure in patients with type 1 diabetes, including diverse groups.

Why it matters

Potential benefit: If successful, patients could receive earlier warning signs and personalized monitoring to prevent kidney failure.

How similar studies have gone: Prior studies show urinary peptidomics can indicate kidney disease risk, but gaps remain that this study aims to fill.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Costacou, Tina — University of Pittsburgh at Pittsburgh
  • Study coordinator: Costacou, Tina

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.